Condition
Aortic Stenosis With Bicuspid Valve
Total Trials
3
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Recruiting2
Not Yet Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT05511792Not ApplicableRecruitingPrimary
Down Sizing Strategy (HANGZHOU Solution) vs Standard Sizing Strategy TAVR in Bicuspid Aortic Stenosis (Type 0)
NCT05844969Not Yet RecruitingPrimary
Circle Method Observational Project - Non-interventional, Retrospective, Multicenter Data Collection
NCT04722796Not ApplicableRecruiting
HANGZHOU Solution in Bicuspid AS Undergoing TAVR
Showing all 3 trials